Non-ownership Filings
| Enhertu approved in US for 1L HER2+ metastatic BC | Dec. 16, 2025 |
| Holding(s) in Company | Dec. 04, 2025 |
| Block listing Interim Review | Dec. 01, 2025 |
| Total Voting Rights | Dec. 01, 2025 |
| Imfinzi approved in US for early gastric cancer | Nov. 26, 2025 |
| AstraZeneca manufacturing investment in Maryland | Nov. 24, 2025 |
| Koselugo (selumetinib) approved in the US | Nov. 20, 2025 |
Ownership Update Filings
| Director/PDMR Shareholding | Dec. 19, 2025 |
| Director/PDMR Shareholding | Nov. 14, 2025 |
| Director/PDMR Shareholding | Nov. 10, 2025 |
| Director/PDMR Shareholding | Sep. 25, 2025 |
| Holding(s) in Company | Aug. 28, 2025 |
| Holding(s) in Company | Aug. 26, 2025 |
| Holding(s) in Company | Aug. 21, 2025 |